Mandate

Vinge has advised 4 to 1 Investments, a company jointly held by Första AP-fonden, Andra AP-fonden, Tredje AP-fonden and Fjärde AP-fonden, in connection with Northvolt’s USD 1.1 billion convertible note

August 04, 2022

Vinge has advised 4 to 1 Investments in connection with Northvolt’s USD 1.1 billion convertible note, to finance its expansion of battery cell and cathode material production in Europe.

Investors participating in the capital raise included, in addition to 4 to 1 Investments, inter alia AMF, Ava Investors, Baillie Gifford, Folksam Group, Goldman Sachs Asset Management, Swedbank Robur, TM Capital and Volkswagen Group. With this capital raise, Northvolt has since 2017 secured close to $8 billion in equity and debt to deliver on its plans to establish a supply of sustainable batteries to enable the decarbonization of society.

Vinge’s team consisted of Ulrich Ziche and Joel Wahlberg. Linn Adelwald assisted in financing related matters.

Related

Vinge has advised Vimian Group AB in connection with its uplisting to Nasdaq Stockholm

Vinge has advised Vimian Group AB (publ) in connection with its list change from Nasdaq First North Growth Market to Nasdaq Stockholm’s main market, Large cap. The prospectus was published on 21 March 2025 and the trading on Nasdaq Stockholm commenced on 28 March 2025.
March 28, 2025

Vinge advises Tribune Therapeutics in conjunction with financing round

Vinge advises Tribune Therapeutics, a Swedish biotechnology company focused on developing therapies for fibrotic diseases, in raising 23 MEUR. The financing round includes the previous investors HealthCap, Novo Holding and Innovestor, in addition to the new investors LifeArc Ventures, Industrifonden and Investinor.
March 26, 2025

Vinge advises Dignitana on the public offer from Paxman

Paxman AB (publ) has announced a public offer to the shareholders of Dignitana AB. The total value of the offer is approximately SEK 153 million.
March 24, 2025